IL6 and cancer: The link between IL-6 and oncogenic progression has been widely reported and IL-6 overexpression has been observed in a variety of solid tumors, both in the tumor microenvironment and in the serum of affected patients, which explains why this cytokine has been proposed as a prognostic biomarker and a therapeutic target in cancer (28, 29).